Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) (NCT04076059) | Astellas (Beijing) Pharmaceutical R&D Co., Ltd. | 2019-09-11 |
Track Astellas (Beijing) Pharmaceutical R&D Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.